Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Immunoglobulin Therapy for Patients With Idiopathic Cardiomyopathy and Endomyocardial Biopsy Proven High PVB19 Viral Load

NCT00659386 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT00659386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00659386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Immunoglobulin Therapy for Patients With Idiopathic Cardiomyopathy and Endomyocardial Biopsy Proven High PVB19 Viral Load
Lead sponsor
Maastricht University Medical Center
Phase
Phase 1
Overall status
Unknown status
Start date
February 28, 2009
Completion date
August 31, 2010
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure